Hepatitis E vaccine recombinant - Japanese National Institute of Infectious Diseases
Alternative Names: rHEV-VLPLatest Information Update: 24 Apr 2002
At a glance
- Originator Nonindustrial source
- Class Synthetic vaccines; Viral hepatitis vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Hepatitis E
Most Recent Events
- 02 Aug 2000 New profile
- 02 Aug 2000 Preclinical development for Hepatitis E in Japan (PO)